What Candid Health Announced About the Flatiron Health Partnership
Candid Health said on 27 August 2026 that it is partnering with Flatiron Health to bring revenue cycle automation to oncology practices in Flatiron's network, with Flatiron integrating the platform into its OncoEMR records system. Candid Health says OncoEMR is used by more than 5,100 providers and more than 220 community oncology practices across the United States, and that it already does this work for some of the largest oncology organisations in the country.
Why the Candid Health and Flatiron Partnership Matters to Oncology Practices
Selling through the records system a practice already uses removes the hardest part of revenue cycle software, which is the integration. For a community oncology practice this is the difference between a project and a setting. The announcement names no practice that has switched, so the useful question is how many of those 220 actually turn it on and what their denial rate does afterwards. Oncology billing also leans on drug costs and prior authorisation, so general claim automation results do not transfer to it unchanged.
Where the Candid Health Update Comes From
Candid Health is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
Candid Health original source.
How We Would Research the Candid Health Flatiron Partnership
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would ask Candid Health for a named oncology reference practice and talk to its billing manager, not its administrator.
- Then we would ask what the integration covers for drug and infusion billing specifically, since that is where the money sits in oncology.
- We would check what happens at renewal if a practice leaves OncoEMR, because software bought through a records system is harder to unpick.